Regenerative medicine and stem cell therapy
4 European H2020 organizations list this as part of their work — 1 as their primary capability.
Most active in this area
- ACADEMISCH ZIEKENHUIS LEIDEN
Major Dutch academic hospital leading European research in immunology, regenerative medicine, medical imaging, and biomarker-driven precision medicine.
“Coordinated RETHRIM (tissue regeneration in graft-vs-host disease) and STEMCARDIORISK, participated in ARISE (heart valve tissue engineering), NEPHSTROM (stromal cell therapy), and EuroStemCell.”
PrimaryNL156 projects - CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL
Brussels university hospital contributing clinical trial expertise in pain medicine, cancer immunotherapy, and patient stratification to European research consortia.
“SEPCELL project on restoring immune homeostasis in severe sepsis using adipose tissue-derived allogeneic stem cells — their highest-funded single project at EUR 534,375.”
BE13 projects - CENTRE HOSPITALIER UNIVERSITAIRE DE GRENOBLE
French university hospital contributing clinical neuroscience expertise to the Human Brain Project and running stem cell and transplant clinical trials.
“RESSTORE (stem cell therapy for stroke), ADIPOA2 (mesenchymal stromal cells for osteoarthritis), and BIOCAPAN (pancreatic islet implants).”
FR12 projects - CAPACITES
Nantes-based technology transfer SME providing contract research in industrial biotechnology, regenerative medicine, and advanced manufacturing.
“Contributed to iPSpine, focused on induced pluripotent stem cell-based therapy for spinal disc regeneration using biomaterials.”
SMEFR4 projects